PURPOSE: In contrast to [1-(13) C]pyruvate, hyperpolarized [2-(13) C]pyruvate permits the ability to follow the (13) C label beyond flux through pyruvate dehydrogenase complex and investigate the incorporation of acetyl-coenzyme A into different metabolic pathways. However, chemical shift imaging (CSI) with [2-(13) C]pyruvate is challenging owing to the large spectral dispersion of the resonances, which also leads to severe chemical shift displacement artifacts for slice-selective acquisitions. METHODS: This study introduces a sequence for three-dimensional CSI of [2-(13) C]pyruvate using spectrally selective excitation of limited frequency bands containing a subset of metabolites. Dynamic CSI data were acquired alternately from multiple frequency bands in phantoms for sequence testing and in vivo in rat heart. RESULTS: Phantom experiments verified the radiofrequency pulse design and demonstrated that the signal behavior of each group of resonances was unaffected by excitation of the other frequency bands. Dynamic three-dimensional (13) C CSI data demonstrated the sequence capability to image pyruvate, lactate, acetylcarnitine, glutamate, and acetoacetate, enabling the analysis of organ-specific spectra and metabolite time courses. CONCLUSIONS: The presented method allows CSI of widely separated resonances without chemical shift displacement artifact, acquiring multiple frequency bands alternately to obtain dynamic time-course information. This approach enables robust imaging of downstream metabolic products of acetyl-coenzyme A with hyperpolarized [2-(13) C]pyruvate.
PURPOSE: In contrast to [1-(13) C]pyruvate, hyperpolarized [2-(13) C]pyruvate permits the ability to follow the (13) C label beyond flux through pyruvate dehydrogenase complex and investigate the incorporation of acetyl-coenzyme A into different metabolic pathways. However, chemical shift imaging (CSI) with [2-(13) C]pyruvate is challenging owing to the large spectral dispersion of the resonances, which also leads to severe chemical shift displacement artifacts for slice-selective acquisitions. METHODS: This study introduces a sequence for three-dimensional CSI of [2-(13) C]pyruvate using spectrally selective excitation of limited frequency bands containing a subset of metabolites. Dynamic CSI data were acquired alternately from multiple frequency bands in phantoms for sequence testing and in vivo in rat heart. RESULTS: Phantom experiments verified the radiofrequency pulse design and demonstrated that the signal behavior of each group of resonances was unaffected by excitation of the other frequency bands. Dynamic three-dimensional (13) C CSI data demonstrated the sequence capability to image pyruvate, lactate, acetylcarnitine, glutamate, and acetoacetate, enabling the analysis of organ-specific spectra and metabolite time courses. CONCLUSIONS: The presented method allows CSI of widely separated resonances without chemical shift displacement artifact, acquiring multiple frequency bands alternately to obtain dynamic time-course information. This approach enables robust imaging of downstream metabolic products of acetyl-coenzyme A with hyperpolarized [2-(13) C]pyruvate.
Authors: Charles H Cunningham; Albert P Chen; Michael Lustig; Brian A Hargreaves; Janine Lupo; Duan Xu; John Kurhanewicz; Ralph E Hurd; John M Pauly; Sarah J Nelson; Daniel B Vigneron Journal: J Magn Reson Date: 2008-03-23 Impact factor: 2.229
Authors: Peder E Z Larson; Adam B Kerr; Christine Leon Swisher; John M Pauly; Daniel B Vigneron Journal: J Magn Reson Date: 2012-10-17 Impact factor: 2.229
Authors: Klaes Golman; René In't Zandt; Mathilde Lerche; Rikard Pehrson; Jan Henrik Ardenkjaer-Larsen Journal: Cancer Res Date: 2006-11-15 Impact factor: 12.701
Authors: Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle Journal: Nat Med Date: 2007-10-28 Impact factor: 53.440
Authors: Charles H Cunningham; Albert P Chen; Mark J Albers; John Kurhanewicz; Ralph E Hurd; Yi-Fen Yen; John M Pauly; Sarah J Nelson; Daniel B Vigneron Journal: J Magn Reson Date: 2007-06-02 Impact factor: 2.229
Authors: Marie A Schroeder; Helen J Atherton; Daniel R Ball; Mark A Cole; Lisa C Heather; Julian L Griffin; Kieran Clarke; George K Radda; Damian J Tyler Journal: FASEB J Date: 2009-03-27 Impact factor: 5.191
Authors: S J Kohler; Y Yen; J Wolber; A P Chen; M J Albers; R Bok; V Zhang; J Tropp; S Nelson; D B Vigneron; J Kurhanewicz; R E Hurd Journal: Magn Reson Med Date: 2007-07 Impact factor: 3.737
Authors: He Zhu; Lori R Arlinghaus; Jennifer G Whisenant; Ming Li; John C Gore; Thomas E Yankeelov Journal: NMR Biomed Date: 2014-07-01 Impact factor: 4.044
Authors: Eugene Milshteyn; Cornelius von Morze; Galen D Reed; Hong Shang; Peter J Shin; Zihan Zhu; Hsin-Yu Chen; Robert Bok; Andrei Goga; John Kurhanewicz; Peder E Z Larson; Daniel B Vigneron Journal: Magn Reson Imaging Date: 2017-01-07 Impact factor: 2.546
Authors: Irene Marco-Rius; Peng Cao; Cornelius von Morze; Matthew Merritt; Karlos X Moreno; Gene-Yuan Chang; Michael A Ohliger; David Pearce; John Kurhanewicz; Peder E Z Larson; Daniel B Vigneron Journal: Magn Reson Med Date: 2016-03-28 Impact factor: 4.668
Authors: Andrew Cho; Justin Y C Lau; Benjamin J Geraghty; Charles H Cunningham; Kayvan R Keshari Journal: J Nucl Med Date: 2017-06-08 Impact factor: 10.057
Authors: Zhen J Wang; Michael A Ohliger; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; James Slater; Javier E Villanueva-Meyer; Christopher P Hess; John Kurhanewicz; Daniel B Vigneron Journal: Radiology Date: 2019-03-05 Impact factor: 11.105
Authors: Peng Cao; Peter J Shin; Ilwoo Park; Chloe Najac; Irene Marco-Rius; Daniel B Vigneron; Sarah J Nelson; Sabrina M Ronen; Peder E Z Larson Journal: Magn Reson Med Date: 2016-05-26 Impact factor: 4.668